Literature DB >> 30553198

Metabotropic glutamate receptor 5 signalling induced NMDA receptor subunits alterations during the development of morphine-induced antinociceptive tolerance in mouse cortex.

Min Huang1, Limin Luo1, Yu Zhang1, Wenying Wang1, Jing Dong1, Wenjie Du1, Wei Jiang2, Tao Xu3.   

Abstract

BACKGROUND AND
PURPOSE: The aim of this study was to investigate the interactions between mGluR5 and NMDAR during the development of tolerance to the analgesic effect of chronic morphine following disruption of the link between mGluR5 and NMDAR.
METHODS: For these experiments, mGluR5 knockout (KO) mice, Shank3 ΔC mutant mice and their littermate controls were used. Repeated morphine treatment through intrathecal injections (i.t. 10 μg/10 μl twice daily for 5 days) was used to induce antinociceptive tolerance and thermal hyperalgesia, which was determined by tail-flick latency and calculated as a percentage of the maximum possible effect (%MPE). Expression of NMDAR subunits (NR1, NR2A and NR2B) and phosphorylation of NR2B in cortex were evaluated by Western blot.
RESULTS: Chronic morphine treatment increased the total expression of mGluR5 and NR2A but not NR1 and NR2B in the cortex and enhanced the phosphorylation of NR2B in wild-type mice after tolerance developed. mGluR5 KOs had attenuated morphine-induced tolerance and thermal hyperalgesia and reduced chronic morphine-induced phosphorylation of NR2B but not total NR2A expression. Shank3 ΔC mice were used to imitate the loss of the physiological connection between mGluR5 and NMDAR, and the mice showed a similar analgesic effect to morphine as their littermate controls, and there were no differential effects on NMDAR subunits compared with controls during the development of morphine-induced tolerance.
CONCLUSIONS: It may be mGluR5-mediated PKC signalling that plays the most significant role in the mechanisms underlying morphine-induced antinociceptive tolerance rather than the physiological connection between mGluR5 and NMDAR.
Copyright © 2018 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Hyperalgesia; Morphine; NMDA receptor; Shank3; Tolerance; mGluR5

Mesh:

Substances:

Year:  2018        PMID: 30553198     DOI: 10.1016/j.biopha.2018.12.042

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  5 in total

1.  Yokukansan Inhibits the Development of Morphine Tolerance by Regulating Presynaptic Proteins in DRG Neurons.

Authors:  Yusuke Ohashi; Fatma Zahra Sakhri; Hideshi Ikemoto; Takayuki Okumo; Naoki Adachi; Masataka Sunagawa
Journal:  Front Pharmacol       Date:  2022-05-18       Impact factor: 5.988

2.  Mechanisms, diagnosis, prevention and management of perioperative opioid-induced hyperalgesia.

Authors:  Sylvia H Wilson; Kevin M Hellman; Dominika James; Adam C Adler; Arvind Chandrakantan
Journal:  Pain Manag       Date:  2021-03-29

Review 3.  Synthesis of the Mechanisms of Opioid Tolerance: Do We Still Say NO?

Authors:  Laura J Gledhill; Anna-Marie Babey
Journal:  Cell Mol Neurobiol       Date:  2021-03-11       Impact factor: 5.046

4.  Expression of SH3 and Multiple Ankyrin Repeat Domains Protein 3 in Mouse Retina.

Authors:  Yue Xu; Ya'nan Wang; Guang'an Tong; Lin Li; Juan Cheng; Lesha Zhang; Qi Xu; Liecheng Wang; Pingping Zhang
Journal:  Front Cell Neurosci       Date:  2022-03-25       Impact factor: 5.505

5.  Angiotensin II receptor type 1 blocker candesartan improves morphine tolerance by reducing morphine‑induced inflammatory response and cellular activation of BV2 cells via the PPARγ/AMPK signaling pathway.

Authors:  Wenxin Zhao; Feiyan Shen; Jixiang Yao; Shanshan Su; Zhongmin Zhao
Journal:  Mol Med Rep       Date:  2022-08-25       Impact factor: 3.423

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.